Xunlei Limited
Xunlei Limited (XNET) Financial Performance & Income Statement Overview
Analyze Xunlei Limited (XNET) financial statements (income, balance sheet, and cash flow) across both yearly and quarterly periods.
Xunlei Limited (XNET) Income Statement & Financial Overview
Review Xunlei Limited XNET income statement with detailed quarterly and annual figures.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $88.45M | $83.99M | $79.84M | $79.33M |
| Cost of Revenue | $44.35M | $40.42M | $39.38M | $38.63M |
| Gross Profit | $44.10M | $43.57M | $40.46M | $40.70M |
| Gross Profit Ratio | $0.50 | $0.52 | $0.51 | $0.51 |
| R&D Expenses | $18.74M | $18.72M | $17.74M | $17.47M |
| SG&A Expenses | $27.31M | $24.56M | $22.82M | $22.26M |
| Operating Expenses | $45.99M | $64.10M | $40.63M | $39.73M |
| Total Costs & Expenses | $90.34M | $104.52M | $80.01M | $78.37M |
| Interest Income | $1.07M | $1.17M | $1.23M | $1.26M |
| Interest Expense | $220000.00 | $139000.00 | $165000.00 | $182000.00 |
| Depreciation & Amortization | $0.00 | $0.00 | $6.05M | $235000.00 |
| EBITDA | $419000.00 | -$17.82M | $5.88M | $4.77M |
| EBITDA Ratio | $0.005 | -$0.21 | $0.07 | $0.06 |
| Operating Income | -$1.89M | -$20.53M | -$174000.00 | $967000.00 |
| Operating Income Ratio | -$0.02 | -$0.24 | -$0.002 | $0.01 |
| Other Income/Expenses (Net) | $2.09M | $2.58M | $5.88M | $3.62M |
| Income Before Tax | $199000.00 | -$17.95M | $5.71M | $4.58M |
| Income Before Tax Ratio | $0.002 | -$0.21 | $0.07 | $0.06 |
| Income Tax Expense | $1.15M | -$8.08M | $1.33M | $2.06M |
| Net Income | -$800000.00 | -$9.77M | $4.59M | $2.75M |
| Net Income Ratio | -$0.009 | -$0.12 | $0.06 | $0.03 |
| EPS | -$0.07 | -$0.80 | $0.07 | $0.04 |
| Diluted EPS | -$0.07 | -$0.80 | $0.07 | $0.04 |
| Weighted Avg Shares Outstanding | $12.24M | $12.55M | $63.48M | $64.14M |
| Weighted Avg Shares Outstanding (Diluted) | $12.24M | $12.55M | $63.58M | $64.18M |
Financial performance has remained strong, with revenue growing from $79.33M in Q2 2024 to $88.45M in Q1 2025. Gross profit continued to perform well, with margins at 50% in the latest quarter. Operating income reached -$1.89M in Q1 2025, holding a steady -2% margin. While R&D and SG&A expenses fluctuated, EBITDA remained robust at $419000.00. Net income rose to -$800000.00, keeping EPS at -$0.07. With disciplined cost control and operational efficiency, the company supported consistent profitability, reflecting its ability to deliver stable shareholder value.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan